Publications by authors named "Ryan Weight"

Claim this Profile
P
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.
Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, Glenn J Hanna, Douglas E Laux, Ryan M Weight

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Soo J Park, David M Ellison, Ryan Weight, Jade Homsi, Guilherme Rabinowits

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Mario E Lacouture, Elena Goleva, Neil Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Ryan Weight

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience.
Anusha Shirwaikar Thomas, Seung Eun Lee, Malek Shatila, Enrico N De Toni, Helga-Paula Török, Ryan Weight

Am J Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Nabanita Mukherjee, Carol M Amato, Jenette Skees, Kaleb J Todd, Karoline A Lambert, Ryan M Weight

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
John A Thompson, Bryan J Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Ryan M Weight

J Natl Compr Canc Netw· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Marlana Orloff, Ryan Weight, Matias E Valsecchi, Takami Sato

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.
Asad Javed, David Arguello, Curtis Johnston, Zoran Gatalica, Mizue Terai, Ryan M Weight

Immunotherapy· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.
Mizue Terai, Zhaomei Mu, David J Eschelman, Carin F Gonsalves, Ken Kageyama, Ryan Weight

EBioMedicine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells by photoacoustic flowmetry.
Ryan M Weight, John A Viator

Methods Mol Biol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical Photoacoustic Detection of Circulating Melanoma Cells In Vitro.
G Gutiérrez-Juárez, S K Gupta, Ryan M Weight, L Polo-Parada, C Papagiorgio

Int J Thermophys· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating melanoma cells in human blood using photoacoustic flowmetry.
Ryan M Weight, Paul S Dale, John A Viator

Annu Int Conf IEEE Eng Med Biol Soc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoacoustic detection of metastatic melanoma cells in the human circulatory system.
Ryan M Weight, John A Viator, Paul S Dale, Charles W Caldwell, Allison E Lisle

Opt Lett· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis